Literature DB >> 34000523

Multiclass diagnosis of stages of Alzheimer's disease using linear discriminant analysis scoring for multimodal data.

Weiming Lin1, Qinquan Gao2, Min Du3, Weisheng Chen4, Tong Tong5.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease, and mild cognitive impairment (MCI) is a transitional stage between normal control (NC) and AD. A multiclass classification of AD is a difficult task because there are multiple similarities between neighboring groups. The performance of classification can be improved by using multimodal data, but the improvement could be limited with inefficient fusion of multimodal data. This study aims to develop a framework for AD multiclass diagnosis with a linear discriminant analysis (LDA) scoring method to fuse multimodal data more efficiently. Magnetic resonance imaging, positron emission tomography, cerebrospinal fluid biomarkers, and genetic features were first preprocessed by performing age correction, feature selection, and feature reduction. Then, they were individually scored using LDA, and the scores that represent the AD pathological progress in different modalities were obtained. Finally, an extreme learning machine-based decision tree was established to perform multiclass diagnosis using these scores. The experiments were conducted on the AD Neuroimaging Initiative dataset, and accuracies of 66.7% and 57.3% and F1-scores of 64.9% and 55.7% were achieved in three- and four-way classifications, respectively. The results also showed that the proposed framework achieved a better performance than the method that did not score multimodal data and the methods in previous studies, thereby indicating that the LDA scoring strategy is an efficient way for multimodalities fusion in AD multiclass classification.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Extreme learning machine; Linear discriminant analysis; Mild cognitive impairment; Multiclass; Multimodal

Year:  2021        PMID: 34000523     DOI: 10.1016/j.compbiomed.2021.104478

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  4 in total

1.  Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD).

Authors:  Jai Woo Lee; Miguel A Maria-Solano; Thi Ngoc Lan Vu; Sanghee Yoon; Sun Choi
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

2.  Application of Higher Education Management in Colleges and Universities by Deep Learning.

Authors:  Ge Yao
Journal:  Comput Intell Neurosci       Date:  2022-08-10

3.  Accuracy of EEG Biomarkers in the Detection of Clinical Outcome in Disorders of Consciousness after Severe Acquired Brain Injury: Preliminary Results of a Pilot Study Using a Machine Learning Approach.

Authors:  Francesco Di Gregorio; Fabio La Porta; Valeria Petrone; Simone Battaglia; Silvia Orlandi; Giuseppe Ippolito; Vincenzo Romei; Roberto Piperno; Giada Lullini
Journal:  Biomedicines       Date:  2022-08-05

4.  Image Classification of Alzheimer's Disease Based on External-Attention Mechanism and Fully Convolutional Network.

Authors:  Mingfeng Jiang; Bin Yan; Yang Li; Jucheng Zhang; Tieqiang Li; Wei Ke
Journal:  Brain Sci       Date:  2022-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.